Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for Improving the Biosynthetic Yield of Ansamitocin p-3

A technology of biosynthesis and ansamitocin, applied in the field of bioengineering, can solve the problems of low biosynthesis yield and limited commercial application, and achieve the effect of increasing yield and yield

Active Publication Date: 2021-07-30
SHANGHAI JIAO TONG UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the current biosynthetic yield of AP-3 is still low, which limits its wide commercial application. Therefore, increasing the biosynthetic yield of AP-3 has important application value

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for Improving the Biosynthetic Yield of Ansamitocin p-3
  • Method for Improving the Biosynthetic Yield of Ansamitocin p-3
  • Method for Improving the Biosynthetic Yield of Ansamitocin p-3

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Such as figure 1 As shown, this embodiment realizes the construction of three expression plasmids and corresponding bacterial strains through the following specific steps:

[0034] ① Construction of the expression plasmid pIB139-asm13-17, specifically: using the genomic DNA of Actinomyces aurantiaciensis ATCC31565 as a template, using 137F / 137R primers to obtain a 4,451bp end containing NdeI / EcoRI enzymes through PCR amplification The asm13-17 fragment of the cutting site, the resulting gene fragment, is connected to pMD @ On the 19-T vector, asm13-17-19T was obtained; the correctness of the sequence was verified by sequencing, digested with NdeI / EcoRI, and connected with the corresponding digested pIB139 plasmid, and the plasmid for asm13-17 gene expression was obtained pIB139-asm13-17.

[0035]The 137F / 137R primers include: asm13-17-upstream primer (137F), as shown in Seq ID No.3, specifically: 5'-GGGAATTC CATATG GTGCCCGGCGACACCGAC-3'; asm13-17-downstream primer (...

Embodiment 2

[0051] The wild-type strain and the engineering bacteria constructed in Example 1 were shaken for fermentation and culture respectively, and the seed medium used for the culture contained (g / l): yeast extract 10, beef extract 10, anhydrous glucose 5, glycerin 10 and sodium chloride 3; fermentation medium (g / l): anhydrous glucose 5, glycerol 40, yeast extract 10, sucrose 2.5, calcium carbonate 2, dipotassium hydrogen phosphate 0.65, magnesium sulfate heptahydrate 0.5, sulfuric acid heptahydrate Ferrous iron 0.002, calcium carbonate 2, isobutanol 200μl / 60ml, aliquot 60ml / 250ml.

[0052] The fermentation culture of the above-mentioned bacterial strains was cultivated according to the method described in the literature (Lin JX et al., Bioresource Technology, 2011, 102 (2): 1863-1868). After primary and secondary seed cultivation respectively, the wild-type strain ATCC31565 and the constructed The seed solution of the obtained engineered bacteria is inserted into the fermentation m...

Embodiment 3

[0057] Fermentation of AP-3 in 3L-Fermenter

[0058] Seed culture: According to the cultivation of the seed culture solution in Example 2, through the primary and secondary seed cultivation, the secondary seed is cultivated for about 36 hours, and inoculated according to the ratio of 1ml seed solution / 60ml medium.

[0059] Using a 3L fermenter (NBS BioFlo110), prepare 1.8L according to the fermentation medium formula in Example 2, 121°C, and sterilize for 30min, and introduce Actinomyces aurantiacens ATCC31565 and pIB139-asm13-17 in Example 1: AP-asm13-17 of the asmUdpg plasmid: asmUdpg engineering bacteria seeds were aseptically inoculated, and 6ml of isobutanol was added at the same time. The culture conditions were temperature 28°C, pH 7.5, rotation speed 400rpm, ventilation volume 1VVM, K L a=70h -1 Conditions for batch fermentation. The AP-3 output was 547 mg / L as measured by HPLC at the end of the fermentation. The dynamic process of dissolved oxygen, pH, cell mass an...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A method for improving the biosynthetic yield of ansamitocin P-3, by constructing the expression plasmid pIB139-asm13-17 of the asm13-17 gene, constructing the expression plasmid pIB139-asmUdpg of the asmUdpg gene, and constructing the co-expression of the asm13-17 gene and asmUdpg The integrated expression plasmid pIB139‑asm13‑17:asmUdpg corresponding to the gene, and the above expression plasmids are respectively transferred into Actinosynnema pretiosum precious orange (Actinosynnema pretiosum), to achieve the improvement of biosynthetic expression, the present invention can significantly improve Fermentation levels of ansamitocin P‑3.

Description

technical field [0001] The present invention relates to a technology in the field of bioengineering, in particular to a method for improving the biosynthetic output of ansamectin P-3 by improving the supply of precursors through metabolic engineering means. Background technique [0002] Actinomycetes are important microorganisms for the synthesis of anti-inflammatory and anti-tumor drugs. Actinomycetes, one of the prokaryotic groups, are widely distributed in nature. About two-thirds of the discovered antibiotics are produced by actinomycetes, which are closely related to humans. Ansamitocin is a maytansinoid anti-tumor compound produced by Actinomyces aurantiacus (Higashide E et al., Nature, 2002, 270(5639): 721-722), the main components of which are P-2, P -3 and P-4, pharmacological research reports show that these compounds have the effect of treating leukemia and lung cancer, and the antitumor activity of ansamicin P-3 (AP-3) is the best. Trastuzumab, an AP-3 antibody...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/74C12P17/18
CPCC12N15/74C12P17/188
Inventor 钟建江杜志强
Owner SHANGHAI JIAO TONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com